Vinpocetine

长春西丁

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVinpocetine
Drug Alias NameVinpocetina长春西汀长春乙酯VinpocetinumCavinton +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsFetal Alcohol Spectrum DisordersDiabetic NephropathiesEpilepsy +[4
Global Approved IndicationsCerebrovascular Disorders
Approved Indications in ChinaCerebrovascular Disorders
Original Approved Country/TerritoryHungary
Original Approved Date1978/01/01
Country/TerritoryUnited StatesHungaryEgypt +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFetal Alcohol Spectrum DisordersDiabetic NephropathiesCerebrovascular Disorders
Inactive IndicationsEpilepsy

Other Information

ATC CodeN06BX18
Related LinksWikipediaKEGG